Low Dose Pasteur Bacillus Calmette-Guerin Regimen in Stage T1, Grade 3 Bladder Cancer Therapy
- 1 November 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- p. 1602-1605
- https://doi.org/10.1097/00005392-199611000-00014
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Dose-Response of Bacillus Calmette-Guerin in the Treatment of Superficial Bladder CancerJournal of Urology, 1992
- Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: A 10-Year FollowupJournal of Urology, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?Journal of Urology, 1991
- The pT1 G3 Bladder TumourBritish Journal of Urology, 1989
- Bladder Tumors Invading the Lamina propria (Stage A/Tl): Influence of Endovesical Bacillus Calmette-Guérin Therapy on Recurrence and ProgressionEuropean Urology, 1989
- Stage T1, Grade 3 Transitional Cell Carcinoma of the Bladder: An Unfavorable Tumor?Journal of Urology, 1987
- Immunotherapy of Murine Transitional Cell CarcinomaJournal of Urology, 1982
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958